News
Lilly Drug Saves Muscle When Added to Wegovy Weight-Loss Shot
Patients who took an experimental drug from Eli Lilly & Co. together with Novo Nordisk A/S’s Wegovy maintained muscle while losing weight, offering a potential solution to one of the key problems that’s emerged with popular obesity shots.
Novo Nordisk's Weight-loss Drug Trial and Eli Lilly's Promising Obesity Treatment
Novo Nordisk reported mostly mild side effects from its experimental weight-loss drug CagriSema, though results upset investors. Eli Lilly anticipates third-quarter results for its obesity treatment orforglipron in non-diabetics,
Stocktwits on MSN8h
Eli Lilly’s Newest Obesity Drug Candidate Stirs Wall Street Buzz, But Not Everyone’s SoldEli Lilly's experimental obesity therapy bimagrumab drew mixed reactions from Wall Street after the company recently ...
Some doctors are concerned that patients taking weight loss drugs like Wegovy may be losing too much lean mass. A combination ...
New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...
Eli Lilly isn't a one-trick pony. The company's lineup of approved medicines features blockbusters like Verzenio, a cancer ...
While Eli Lilly brushed off concerns about gastrointestinal side effects for oral weight loss candidate orforglipron, ...
Compounded GLP-1s are still accessible on telehealth sites, despite an agreement with Eli Lilly to cease copycat sales.
An obesity drug from China helped patients lose a lot of weight in a late-stage clinical trial, making it a prospective new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback